7Baggers
 4D Molecular Therapeutics Appoints New Financial Officer  TipRanks Fri, 03 Oct 2025 01:27:00 GMT
 4d molecular therapeutics appoints new financial officer  TipRanks Thu, 02 Oct 2025 20:41:13 GMT
 H.C. Wainwright Reaffirms Their Buy Rating on 4D Molecular Therapeutics (FDMT)  The Globe and Mail Sat, 20 Sep 2025 13:18:00 GMT
 4dmt to participate in upcoming investor conferences  富途牛牛 Fri, 12 Sep 2025 18:33:17 GMT
 4DMT Announces New Employment Inducement Grants  GlobeNewswire Fri, 12 Sep 2025 07:00:00 GMT
 Jim Cramer on 4D Molecular Therapeutics: “This is a Pure Spec”  Yahoo Finance Fri, 05 Sep 2025 07:00:00 GMT
 4d molecular therapeutics soars 11.9% on positive outlook  AInvest Thu, 04 Sep 2025 12:39:23 GMT
 published on: 2025-09-03 03:14:03  Newser Wed, 03 Sep 2025 08:14:03 GMT
 4DMT Announces Leadership Expansion with Proven Late-Stage  GlobeNewswire Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-09-01 11:16:39  Newser Mon, 01 Sep 2025 16:16:39 GMT
 published on: 2025-09-01 05:26:16  Newser Mon, 01 Sep 2025 10:26:16 GMT
 published on: 2025-08-29 07:07:23  Newser Fri, 29 Aug 2025 12:07:23 GMT
 published on: 2025-08-28 22:06:52  Newser Fri, 29 Aug 2025 03:06:52 GMT
 published on: 2025-08-28 19:37:35  Newser Fri, 29 Aug 2025 00:37:35 GMT
 published on: 2025-08-28 10:21:56  Newser Thu, 28 Aug 2025 15:21:56 GMT
 published on: 2025-08-28 04:19:38  Newser Thu, 28 Aug 2025 09:19:38 GMT

4D Molecular Therapeutics, Inc
(NASDAQ:FDMT) 

FDMT stock logo

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has t...

Founded: 2013
CEO: David Kirn  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends